Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus
To test the utility of gene therapeutic approaches for the treatment of pain, a recombinant herpes simplex virus, type 1, has been engineered to contain the cDNA for an opioid peptide precursor, human preproenkephalin, under control of the human cytomegalovirus promoter. This virus and a similar rec...
Збережено в:
| Опубліковано в:: | Proc Natl Acad Sci U S A |
|---|---|
| Автори: | , , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
National Academy of Sciences
1999
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC15921/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10077663/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.96.6.3211 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|